Vinflunine
The behavior of vinflunine in routine clinical practice resembles that of the pivotal phase III randomized study. Vinflunine (VFL) -EPR combination is feasible with manageable toxicity. The antitumour activity was promising and supports further evaluation. It underscores a critical function for VFL in cell-cell adhesions of epithelial bladder tumour cells, suggesting a novel molecular mechanism by which VFL may impact upon EMT and metastasis.
Product Specifications
CAS Number
162652-95-1
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO: 100 mg/mL (103.4 mM)
Molecular Formula
C45H54F2N4O8
Molecular Weight
816.93
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
CC[C@@]1 (C=CCN2CC3) [C@@]2 ([H]) [C@@]3 (C (C=C ([C@] (C4=C5C (C=CC=C6) =C6N4) (CC (C[C@@H] (C (F) (F) C) C7) ([H]) CN7C5) C (OC) =O) C (OC) =C8) =C8N9C) [C@]9 ([H]) [C@] (C (OC) =O) (O) [C@@H]1OC (C) =O
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1474789-01 0.02 mg (E-Coli)
Recombinant Viridovipera stejnegeri Stejaggregin-B subunit beta-1
Sign In for Pricing
View Details MBS1474789-02 0.1 mg (E-Coli)
Recombinant Viridovipera stejnegeri Stejaggregin-B subunit beta-1
Sign In for Pricing
View Details MBS1474789-03 0.02 mg (Yeast)
Recombinant Viridovipera stejnegeri Stejaggregin-B subunit beta-1
Sign In for Pricing
View Details MBS1474789-04 0.1 mg (Yeast)
Recombinant Viridovipera stejnegeri Stejaggregin-B subunit beta-1
Sign In for Pricing
View Details MBS1474789-05 0.02 mg (Baculovirus)
Recombinant Viridovipera stejnegeri Stejaggregin-B subunit beta-1
Sign In for Pricing
View Details MBS1474789-06 0.02 mg (Mammalian-Cell)
Recombinant Viridovipera stejnegeri Stejaggregin-B subunit beta-1
Sign In for Pricing
View Details